Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,431 shares, an increase of 256.9% from the August 15th total of 401 shares. Based on an average daily volume of 396 shares, the short-interest ratio is presently 3.6 days. Approximately 0.0% of the company’s stock are short sold.
Orion OYJ Stock Performance
Orion OYJ stock remained flat at $46.00 during mid-day trading on Friday. 18 shares of the company’s stock traded hands, compared to its average volume of 224. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The firm has a market capitalization of $12.98 billion, a PE ratio of 18.93 and a beta of 0.08. Orion OYJ has a 52-week low of $30.89 and a 52-week high of $46.00. The business has a fifty day moving average price of $42.86 and a 200 day moving average price of $40.13.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last issued its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share for the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.The business had revenue of $606.38 million for the quarter.
Orion OYJ Company Profile
Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.
The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.
Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.
Further Reading
- Five stocks we like better than Orion OYJ
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
